SOURCE: annual_report_text (1).txt
CHUNK: 509 of 1106
SIZE: 560 characters
PREVIOUS: chunk_0508_annual_report_text (1).txt
NEXT: chunk_0510_annual_report_text (1).txt
------------------------------
10 For more details on REBIT, refer to Note 15 of the 
consolidated financial statements 
new European Medical Device Regulation 
for EUR 3.7 million; The goodwill at the end 
of 2023 (EUR 10.2 million) relates to the 
Dosimetry business as well as the newly 
acquired business of Fluidomica in Portugal; An increase of tangible assets (used and 
leased) for EUR 3.4 million representing 
more investments on the facilities with new 
solar carports and EV charging stations, as 
well as renewal of the car fleet. === Page 99 ===
IBA Annual Report 2023 
96. IBA